In Biofarma Group's vision lies the ambition of the group and of each of us: to be the first to design a future where innovation is at the service of personalised and sustainable prevention. This is why we have created in our organisation, a team of professionals who every day are sparks and constant stimulus for development and improvement oriented towards a unique and differentiating future: a permanent look at the future, with the awareness that we no longer and only have to rely on internal ideas and resources but also on external solutions, knowledge and technological expertise, thanks to an ecosystem of innovators made up of start-ups, universities, research institutes and suppliers.
Biofarma Group has an established network of collaborations with national and international Key Opinion Leaders who can share future scientific and technological trends. An ecosystem with more than 30 of the best exponents of the scientific community in various areas including gynaecology, cardiometabolics, gastroenterology, orthopaedics, immunology, neurology, geriatrics, pharmacology, urology and andrology. We actively collaborate with scientific and technological start-ups, universities, hospitals and facilities.
The new innovation models also see the large multinationals in the pharmaceutical sector dialoguing in an open system, where knowledge moves fluidly. Even the Biofarma Group, in a pioneering way in the nutraceutical and cosmetics business, is at the forefront of developing increasingly innovative projects and technologies.
Our approach to the customer and the market makes us extremely sensitive to product positioning and the industrial feasibility process, which is why we offer a 4-level approach to innovation:
Bronze Level / conception of new products with innovative raw materials (e.g. novel food and therefore not yet or scarcely present on the market, raw materials selected for the quality of the scientific studies supporting them) and the development of scientific rationale to support them
Silver Level / design of new products supported by scientific dossiers and basic preclinical studies (safety)
Gold Level / conception of new products supported by scientific dossiers, advanced preclinical studies, proof of concept or clinical studies
Platinum Level / conception of new products supported by a pharma-like management and development process
Innovation and sustainability are at the heart of the Biofarma Group's strategy: two key concepts united by a common thread, that of knowledge, continuous and pervasive, able through science to find new solutions to today's complex economic, social and environmental challenges, through a continuous search for talent, ideas and technologies for people's wellbeing, in the conviction that a society more aware of the value of health is a fairer and more sustainable society.
Open Innovation drives the Biofarma Group team across the board in the conception and realisation of innovative products, including the exploration and selection of the best available technologies to conceive and realise them, from the use of AI to product customisation technologies. The patents filed and patent pending demonstrate our constant commitment to finding genuine products and solutions with a high innovation content.
